The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Open accessAbstract
Importance: Deaths due to opioid overdose have tripled in the last decade. Efforts to curb this trend have focused on restricting the prescription opioid supply; however, the near-term effects of such efforts are unknown. Objective: To project effects of interventions to lower prescription opioid misuse on opioid overdose deaths from 2016 to 2025. Design, Setting, and Participants: This system dynamics (mathematical) model of the US opioid epidemic projected outcomes of simulated individuals who engage in nonmedical prescription or illicit opioid use from 2016 to 2025. The analysis was performed in 2018 by retrospectively calibrating the model from 2002 to 2015 data from the National Survey on Drug Use and Health and the Centers for Disease Control and Prevention. Interventions: Comparison of interventions that would lower the incidence of prescription opioid misuse from 2016 to 2025 based on historical trends (a 7.5% reduction per year) and 50% faster than historical trends (an 11.3% reduction per year), vs a circumstance in which the incidence of misuse remained constant after 2015. Main Outcomes and Measures: Opioid overdose deaths from prescription and illicit opioids from 2016 to 2025 under each intervention. Results: Under the status quo, the annual number of opioid overdose deaths is projected to increase from 33 100 in 2015 to 81 700 (95% uncertainty interval [UI], 63 600-101 700) in 2025 (a 147% increase from 2015). From 2016 to 2025, 700 400 (95% UI, 590 200-817 100) individuals in the United States are projected to die from opioid overdose, with 80% of the deaths attributable to illicit opioids. The number of individuals using illicit opioids is projected to increase by 61%-from 0.93 million (95% UI, 0.83-1.03 million) in 2015 to 1.50 million (95% UI, 0.98-2.22 million) by 2025. Across all interventions tested, further lowering the incidence of prescription opioid misuse from 2015 levels is projected to decrease overdose deaths by only 3.0% to 5.3%. Conclusions and Relevance: This study's findings suggest that interventions targeting prescription opioid misuse such as prescription monitoring programs may have a modest effect, at best, on the number of opioid overdose deaths in the near future. Additional policy interventions are urgently needed to change the course of the epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000625 · Cited by 1,152
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
Self-citationSystem Dynamics Modeling for Public Health: Background and Opportunities
Homer, J. B., & Hirsch, G. B. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.062059 · Cited by 976
(2014) · Encyclopedia of Social Deviance · doi:10.4135/9781483340470.n189 · Cited by 630
Massachusetts Department of Public Health
Gallagher, S. S., Guyer, B., Kotelchuck, M., Bass, J., Lovejoy, F. H., McLoughlin, E., & Mehta, K. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071613 · Cited by 591
Office of National Drug Control Policy
(2004) · Encyclopedia of Law Enforcement · doi:10.4135/9781412952415.n342 · Cited by 416
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643e1 · Cited by 387
Prescription Drug Monitoring Programs and Death Rates from Drug Overdose
Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01062.x · Cited by 372
Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1673 · Cited by 322
Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 299
Rutkow, L., Chang, H.-Y., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3931 · Cited by 262
Addressing the Fentanyl Threat to Public Health
Frank, R. G., & Pollack, H. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1615145 · Cited by 242
Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic
Pitt, A. L., Humphreys, K., & Brandeau, M. L. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304590 · Cited by 234
Fink, D. S., Schleimer, J. P., Sarvet, A., Grover, K. K., Delcher, C., Castillo-Carniglia, A., Kim, J. H., Rivera-Aguirre, A. E., Henry, S. G., Martins, S. S., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3074 · Cited by 213
Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States
Cicero, T. J., Ellis, M. S., & Harney, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505541 · Cited by 175
Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities
Wakeman, S. E., & Barnett, M. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1802741 · Cited by 175
Self-citationDo more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo, B. (2017) · Addiction · doi:10.1111/add.13741 · Cited by 174
Prescription Drug Monitoring and Dispensing of Prescription Opioids
Brady, J. E., Wunsch, H., DiMaggio, C., Lang, B. H., Giglio, J., & Li, G. (2014) · Public Health Reports® · doi:10.1177/003335491412900207 · Cited by 164
Increased use of heroin as an initiating opioid of abuse
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.05.030 · Cited by 153
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages
Haffajee, R. L., Mello, M. M., Zhang, F., Zaslavsky, A. M., Larochelle, M. R., & Wharam, J. F. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1321 · Cited by 135
Self-citationCalibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
Stout, N. K., Knudsen, A. B., Kong, C. Y., McMahon, P. M., & Gazelle, G. S. (2009) · PharmacoEconomics · doi:10.2165/11314830-000000000-00000 · Cited by 129
Self-citationUnick, G. J., & Ciccarone, D. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.003 · Cited by 128
Wen, H., Schackman, B. R., Aden, B., & Bao, Y. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1141 · Cited by 122
Moyo, P., Simoni‐Wastila, L., Griffin, B. A., Onukwugha, E., Harrington, D., Alexander, G. C., & Palumbo, F. B. (2017) · Addiction · doi:10.1111/add.13860 · Cited by 117
2015 NATIONAL SURVEY ON DRUG USE AND HEALTH
LeBaron, P., McHenry, G., Chen, T. X., & Virag, T. (2015) · Cited by 92
Springer, S. A., Korthuis, P. T., & del Rı́o, C. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1203 · Cited by 64
Overdose Prevention Through Medical Treatment of Opioid Use Disorders
Volkow, N., & Wargo, E. M. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1397 · Cited by 48
Yarbrough, C. R. (2017) · Health Services Research · doi:10.1111/1475-6773.12652 · Cited by 42
Langston, A. A., Prichard, J. M., Muppidi, S., Nooka, A. K., Lechowicz, M. J., Lonial, S., Sinha, R., Graiser, M., Kaufman, J. L., Khoury, H. J., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.168 · Cited by 20
Research works printed but not linked: 1
- Sun, 2018, Effect of automated prescription drug monitoring program queries on emergency department opioid prescribing., Ann of Emerg Med, 71, 337, 10.1016/j.annemergmed.2017.10.023 · doi:10.1016/j.annemergmed.2017.10.023
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995
Self-citationGlobal patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Self-citationGoedel, W. C., Shapiro, A., Cerdá, M., Tsai, J. W., Hadland, S. E., & Marshall, B. D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3711 · Cited by 295
Metadata
- Authors
- Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., Pandharipande, P. V., & Chhatwal, J.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2019-02-01
- Volume
- 2
- Issue
- 2
- Pages
- e187621
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W2913621448
- Cited by
- 274
- References
- 31
- FWCI
- 40.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.